Is it safe for individuals with Glucose-6-phosphate dehydrogenase (G6PD) deficiency to consume edamame?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Safety of Edamame Consumption in G6PD Deficiency

Edamame (soybeans) can be safely consumed by individuals with G6PD deficiency as there is no evidence linking it to hemolytic reactions.

Understanding G6PD Deficiency and Food Triggers

Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common enzyme deficiency worldwide, affecting more than 400 million people 1. This X-linked genetic disorder primarily affects males but can also occur in females. G6PD deficiency renders individuals susceptible to hemolytic anemia when exposed to certain oxidative stressors.

Known Food Triggers for G6PD Deficiency

The primary food-related concern for individuals with G6PD deficiency is:

  • Fava beans (broad beans): The only food with conclusive clinical evidence linking it to hemolytic anemia in G6PD-deficient individuals 2

Other legumes that have been reported to potentially cause hemolysis in some cases include:

  • Falafel
  • Chickpeas
  • Green peas
  • Peanuts
  • Lentils
  • Black-eyed peas 3

Edamame and G6PD Deficiency

Edamame, which are immature soybeans, are not included in any guidelines or research as a trigger for hemolytic reactions in G6PD deficiency. A comprehensive review of dietary restrictions for people with G6PD deficiency found that fava beans were the only food with conclusive clinical evidence linking it to hemolytic anemia 2.

Clinical Decision Making for G6PD-Deficient Patients

When advising patients with G6PD deficiency about diet:

  1. Definitely avoid: Fava beans (broad beans) - these have the strongest association with hemolytic crises 3, 2, 4

  2. Monitor with caution: Other legumes like chickpeas, lentils, and peanuts - these have been reported in some cases but evidence is less conclusive 3

  3. Generally safe: Edamame (soybeans) - no evidence linking them to hemolytic reactions in G6PD deficiency

Additional Precautions for G6PD-Deficient Individuals

Beyond food considerations, individuals with G6PD deficiency should:

  • Avoid certain medications: Specifically dapsone, methylene blue, nitrofurantoin, phenazopyridine, primaquine, rasburicase, and toluidine blue 5

  • Be cautious during infections: Infections are the second most common trigger of hemolysis in G6PD-deficient individuals (12.4% of cases) 3

  • Know the symptoms of hemolysis: Pallor, dark red urine, and jaundice typically occurring 24-72 hours after exposure to a trigger 3

Monitoring Recommendations

If a G6PD-deficient individual tries a new food and is concerned about potential reactions:

  • Watch for symptoms of hemolysis (pallor, jaundice, dark urine)
  • Seek medical attention if these symptoms develop
  • Consider having laboratory tests (complete blood count, reticulocyte count) if symptoms occur

Conclusion

While G6PD-deficient individuals must strictly avoid fava beans and certain medications, current evidence does not suggest that edamame (soybeans) pose a risk for hemolytic reactions. Patients should still be vigilant for any unusual symptoms after consuming any legumes, but edamame can generally be considered safe for consumption by individuals with G6PD deficiency.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.